Related Articles
The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival
Response‑specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long‑term exposure to medroxyprogesterone acetate
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
Effects of progestins of human proliferative endometrium: An in vitro model of potential clinical relevance
Progestin therapy for endometrial cancer: The potential of fourth-generation progestin (Review)